AMA issues report on implantable RFID chips
Last week the American Medical Association (AMA) issued a report on the use of implanted radio frequency identification (RFID)-based technology used for tracking patients and accessing their information.
The Food and Drug Administration approved the use of RFID technology in 2004, although there may be some risks associated with its use. RFID technology may promote the timely identification of patients, expedite access to their medical information, and improve coordination and continuity of care through the reduction in medical errors and adverse drug events. The AMA recommended that use of this technology be used with patient consent after the potential risks have been described to the patient.
Access the report at: http://www.ama-assn.org/ama1/pub/upload/mm/467/ceja5a07.doc.
The Food and Drug Administration approved the use of RFID technology in 2004, although there may be some risks associated with its use. RFID technology may promote the timely identification of patients, expedite access to their medical information, and improve coordination and continuity of care through the reduction in medical errors and adverse drug events. The AMA recommended that use of this technology be used with patient consent after the potential risks have been described to the patient.
Access the report at: http://www.ama-assn.org/ama1/pub/upload/mm/467/ceja5a07.doc.